Delivery Order SPE2DR25D3301-SPE2DR26F19FU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,118.25 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (undivided 30-count packaging) with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,990.86 to supply Micardis HCT 80-25 mg tablet unit dose packs (30 count) with an ultimate completion date of December 3, 2025. This non-set-aside contract employs firm fixed pricing and represents a competitive delivery order under AmerisourceBergen's existing federal supply agreements. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $27,546.64 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Micardis HCT 80-25 mg tablets (unit dose, 30-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025....
- The Defense Logistics Agency awarded a delivery order valued at $2,933.79 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose packages) with a completion date of November 18, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,476.51 to AmerisourceBergen Drug Corp for the supply of Micardis HCT 40-12.5 mg tablets (30-count unit dose packaging) with an ultimate completion date of September 10, 2025. This competitive award, issued on September 9, 2025, utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,044.82 to supply Micardis HCT 80-25 mg tablet unit dose packages (30 count) with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a contract value of $2,342.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Micardis HCT 80-25 mg tablet unit dose packages (30-count) with a ceiling value of $2,217.60. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Micardis HCT 40-12.5 mg tablets in unit dose packaging (30 count) with a contract value of $4,957.67 and an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed under a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,243.66 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Micardis HCT 40-12.5 mg tablets (30 unit dose tablets). This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania, with an...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19FUDelivery Order
The Defense Logistics Agency awarded a $1,207.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging). This non-set-aside contract was executed on December 9, 2025, with an ultimate completion date of December 10, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement action within the company's broader federal supply portfolio. This award is a child delivery order issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's role as a major pharmaceutical distributor positions it as a critical vendor for federal medical procurement, serving defense health systems including the Defense Health Agency and U.S. Coast Guard through competitively awarded contracts demonstrating capability to meet federal requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/8/25 |